|
Welcome to datamethods
|
|
0
|
13966
|
July 12, 2018
|
|
Important Paper: Why almost all ML models for medicine are wrong-and what we need for evidence-based medical AI
|
|
11
|
430
|
September 24, 2026
|
|
Randomized non-comparative trials: an oxymoron?
|
|
90
|
5419
|
September 22, 2026
|
|
Statistics Agent Skills for Large Language Models
|
|
17
|
1543
|
September 21, 2026
|
|
[DCGs] Feedback loops and circular causality
|
|
3
|
128
|
September 21, 2026
|
|
FDA Draft Guidance: Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products
|
|
15
|
1421
|
September 20, 2026
|
|
Causal Formalism and RCTs
|
|
22
|
585
|
September 14, 2026
|
|
What Should a Newly Applied Statistician Know Beyond the Standard Ciriculum
|
|
7
|
233
|
September 13, 2026
|
|
RCT & Synthetic Data Generating Processes
|
|
0
|
67
|
September 13, 2026
|
|
Sequel to the odds ratio story
|
|
14
|
399
|
September 11, 2026
|
|
Cobra effect and p values
|
|
10
|
371
|
September 10, 2026
|
|
Bayesian predictive projection for variable selection
|
|
18
|
727
|
September 5, 2026
|
|
Oseltamivir (Tamiflu) again proves the need for RCT
|
|
15
|
724
|
August 31, 2026
|
|
CPMs for competing risks and multi-state models
|
|
7
|
324
|
August 26, 2026
|
|
Discussion of Assessing Heterogeneity of Treatment Effect, Estimating Patient-Specific Efficacy, and Studying Variation in Odds ratios, Risk Ratios, and Risk Differences
|
|
37
|
13556
|
August 23, 2026
|
|
Multiple imputation bootstrap validation and group lasso
|
|
5
|
230
|
August 23, 2026
|
|
Use of cpower function in Hmisc package
|
|
7
|
1832
|
August 22, 2026
|
|
Bayesian prediction when you have the whole population?
|
|
24
|
713
|
August 20, 2026
|
|
Reanalyzing MERIT design using Julia + recent numerical algorithms
|
|
5
|
401
|
August 11, 2026
|
|
Royal Statistical Society Discussion on Randomization vs Model Based Inference July 1, 2026
|
|
35
|
1673
|
August 11, 2026
|
|
Clinicians increased awareness of RCT structure
|
|
1
|
231
|
August 8, 2026
|
|
Complex decisions based on multivariate outcomes in Bayesian world
|
|
6
|
233
|
August 7, 2026
|
|
French target trial using obs data of HCQ vs not in SARS-CoV-2 infection
|
|
10
|
3582
|
August 5, 2026
|
|
Where are the exceptional responders?
|
|
12
|
1463
|
August 4, 2026
|
|
How to interpret “confidence intervals” in observational studies
|
|
259
|
5830
|
August 2, 2026
|
|
Does a Bayesian "p > 0.5" translate as "probably"?
|
|
9
|
320
|
July 30, 2026
|
|
Statistical Models Answer the Fundamental Clinical Question and Provide Clinical Trial Estimands
|
|
1
|
256
|
July 28, 2026
|
|
Combining Sensitivity and NPV in a meta-analysis
|
|
3
|
226
|
July 26, 2026
|
|
Statistical Process Control and Experimental Design
|
|
10
|
649
|
July 8, 2026
|
|
RMS Discussions
|
|
395
|
103221
|
July 7, 2026
|